RightFit Trial Directory

Lung Cancer clinical trials in Winston-Salem, NC

13 recruiting lung cancer studies with a site in Winston-Salem, NC.

All trials in Winston-Salem, NC · All Lung Cancer trials

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Asheboro, NC · +1147 more sites

RecruitingPhase 3NCT06623422

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Sponsor: Merck Sharp & Dohme LLC

Charlotte, NC · Winston-Salem, NC · +52 more sites

RecruitingNot applicableNCT07059884

Distance-Based Exercise to Preserve Function and Prevent Disability

Sponsor: Alliance for Clinical Trials in Oncology

Kernersville, NC · Mount Airy, NC · Winston-Salem, NC · +20 more sites

RecruitingPhase 3NCT07361497

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Sponsor: Bristol-Myers Squibb

Winston-Salem, NC · +37 more sites

RecruitingPhase 3NCT07361510

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Sponsor: Bristol-Myers Squibb

Winston-Salem, NC · +40 more sites

RecruitingPhase 1NCT05877599

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Sponsor: AstraZeneca

Charlotte, NC · Winston-Salem, NC · +18 more sites

RecruitingPhase 2NCT04253964

Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

Sponsor: Wake Forest University Health Sciences

Charlotte, NC · Winston-Salem, NC

RecruitingPhase 2 / Phase 3NCT07063745

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Sponsor: Bristol-Myers Squibb

Winston-Salem, NC · +43 more sites

RecruitingPhase not listedNCT06567704

Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

Sponsor: Wake Forest University Health Sciences

Charlotte, NC · Winston-Salem, NC

RecruitingPhase 2 / Phase 3NCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Sponsor: SWOG Cancer Research Network

Asheboro, NC · +1226 more sites

RecruitingPhase 3NCT02468024

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Sponsor: University of Texas Southwestern Medical Center

Chapel Hill, NC · Winston-Salem, NC · +38 more sites

RecruitingNot applicableNCT07322367

A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients

Sponsor: Wake Forest University Health Sciences

Winston-Salem, NC

Not yet recruitingNot applicableNCT07282444

A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial

Sponsor: Wake Forest University Health Sciences

Winston-Salem, NC

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.